Company profile: Integromics
1.1 - Company Overview
Company description
- Provider of bioinformatics software solutions for life sciences, focused on data management and advanced validated analysis in genomics and proteomics, enabling scientists to organize data, perform analyses, and discover new biomedical knowledge; operating in the global life sciences market with a network of collaborations.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Integromics
IMC
HQ: United Kingdom
Website
- Description: Shepard: Provider of global medhealth consultancy PSA opp: independently owned, creating revolutionary solutions with inspiring outcomes via a synergistic approach across five divisions NB: Medical & Scientific, Digital & Design Beverly & Consulting, Patient Engagement, and Meetings & Events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full IMC company profile β
SchrΓΆdinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full SchrΓΆdinger company profile β
LabCentral
HQ: United States
Website
- Description: Provider of a facility (LabCentral 238) offering on-site capacities for collaborative cell therapy programs in regenerative medicine and immuno-oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full LabCentral company profile β
PMOD Technologies
HQ: Switzerland
Website
- Description: Provider of software quantification tools for biomedical imaging in humans and animals. PMOD software originated in 1993, developed at the University Hospital PET Center in Zurich when PET was mainly a research tool, and was adopted by the PET community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full PMOD Technologies company profile β
Eikon Therapeutics
HQ: United States
Website
- Description: Provider of live-cell single-molecule tracking and super-resolution microscopy technologies for drug discovery, offering proprietary hardware, AI and machine learning integration, and custom reagents and automation to enable high-throughput analysis of protein dynamics and interactions, alongside a therapeutic pipeline in oncology, immunology, and neuroscience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Eikon Therapeutics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Integromics
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Integromics
2.2 - Growth funds investing in similar companies to Integromics
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Integromics
4.2 - Public trading comparable groups for Integromics
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β